These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16941956)

  • 1. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs.
    Li J; Liu Y; Zhang JW; Wei H; Yang L
    Comp Med; 2006 Aug; 56(4):286-90. PubMed ID: 16941956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT; Chang YW; Lan SJ; Yeh TK
    Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse.
    Chauret N; Gauthier A; Martin J; Nicoll-Griffith DA
    Drug Metab Dispos; 1997 Oct; 25(10):1130-6. PubMed ID: 9321515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
    Tang J; Amin Usmani K; Hodgson E; Rose RL
    Chem Biol Interact; 2004 Apr; 147(3):319-29. PubMed ID: 15135087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
    Newton DJ; Wang RW; Lu AY
    Drug Metab Dispos; 1995 Jan; 23(1):154-8. PubMed ID: 7720520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes.
    Chauret N; Gauthier A; Nicoll-Griffith DA
    Drug Metab Dispos; 1998 Jan; 26(1):1-4. PubMed ID: 9443844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities.
    Hickman D; Wang JP; Wang Y; Unadkat JD
    Drug Metab Dispos; 1998 Mar; 26(3):207-15. PubMed ID: 9492382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
    Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
    J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028.
    Kim H; Yoon YJ; Kim H; Kang S; Cheon HG; Yoo SE; Shin JG; Liu KH
    Toxicol Lett; 2006 Oct; 166(2):105-14. PubMed ID: 16857327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes.
    Shimada T; Tsumura F; Yamazaki H
    Drug Metab Dispos; 1999 Nov; 27(11):1274-80. PubMed ID: 10534312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of flavonoids isolated from Scutellariae radix on cytochrome P-450 activities in human liver microsomes.
    Kim JY; Lee S; Kim DH; Kim BR; Park R; Lee BM
    J Toxicol Environ Health A; 2002 Mar; 65(5-6):373-81. PubMed ID: 11936218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of aroclor 1254-induced and uninduced rat liver microsomes to human liver microsomes in phenytoin O-deethylation, coumarin 7-hydroxylation, tolbutamide 4-hydroxylation, S-mephenytoin 4'-hydroxylation, chloroxazone 6-hydroxylation and testosterone 6beta-hydroxylation.
    Easterbrook J; Fackett D; Li AP
    Chem Biol Interact; 2001 May; 134(3):243-9. PubMed ID: 11336973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes.
    Kawashiro T; Yamashita K; Zhao XJ; Koyama E; Tani M; Chiba K; Ishizaki T
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1294-300. PubMed ID: 9732391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of etodolac on P450 isoform-specific activities in human hepatic microsomes.
    Nakamura A; Tougou K; Kitazumi H; Yamada T; Honjou K; Zinno A; Nonaka K; Mukai H
    Arzneimittelforschung; 2005; 55(12):744-8. PubMed ID: 16430028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig.
    Witkamp RF; Nijmeijer SM; Monshouwer M; Van Miert AS
    Drug Metab Dispos; 1995 May; 23(5):542-7. PubMed ID: 7587928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
    Bourrié M; Meunier V; Berger Y; Fabre G
    J Pharmacol Exp Ther; 1996 Apr; 277(1):321-32. PubMed ID: 8613937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the selectivity and mechanism of cytochrome P450 inhibition by dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate.
    Kim JY; Baek M; Lee S; Kim SO; Dong MS; Kim BR; Kim DH
    Drug Metab Dispos; 2001 Dec; 29(12):1555-60. PubMed ID: 11717174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human liver cytochrome P450 enzymes involved in the metabolism of a new H+/K+-ATPase inhibitor KR-60436.
    Ji HY; Lee HW; Kim HH; Choi JK; Lee HS
    Toxicol Lett; 2005 Jan; 155(1):103-14. PubMed ID: 15585365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.